Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Viale

Showing results (271-280 of 302) with videos related to

Pageof 31
Sort By:
Endocrine-Related Cancer|December 18, 2013
Grading the neuroendocrine tumors of the lung: an evidence-based proposalG Rindi, C Klersy, F Inzani, et al.
European Journal of Cancer (Oxford, England : 1990)|January 26, 2025
Survival outcomes for patients with invasive lobular cancer by MammaPrint: Results from the MINDACT phase III trialO Metzger Filho, F Cardoso, C Poncet, et al.
Breast Cancer Research and Treatment|November 28, 2017
Evaluation of applying IHC4 as a prognostic model in the translational study of Intergroup Exemestane Study (IES): PathIESM C U Cheang, J M Bliss, G Viale, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2011
Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IXS Aebi, Z Sun, D Braun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2011
Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancerP Karlsson, Z Sun, D Braun, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 12, 2021
Management of breast cancer patients during the peak of the COVID 19 pandemicE Montagna, F Bellerba, C Sangalli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 4, 2008
Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancerG Gruber, B F Cole, M Castiglione-Gertsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2022
Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized studyL Gianni, C S Huang, D Egle, et al.
ESMO Open|August 10, 2023
Retrospective study to estimate the prevalence and describe the clinicopathological characteristics, treatments received, and outcomes of HER2-low breast cancerG Viale, M Basik, N Niikura, et al.
European Journal of Cancer (Oxford, England : 1990)|February 3, 2024
Multiplexed high-throughput immune cell imaging in patients with high-risk triple negative early breast cancer: Analysis from the International Breast Cancer Study Group (IBCSG) Trial 22-00S Rusakiewicz, S Tyekucheva, S Tissot-Renaud, et al.
Pageof 31

Showing results (271-280 of 302) with videos related to

Sort By:
Pageof 31
Endocrine-Related Cancer|December 18, 2013
Grading the neuroendocrine tumors of the lung: an evidence-based proposalG Rindi, C Klersy, F Inzani, et al.
European Journal of Cancer (Oxford, England : 1990)|January 26, 2025
Survival outcomes for patients with invasive lobular cancer by MammaPrint: Results from the MINDACT phase III trialO Metzger Filho, F Cardoso, C Poncet, et al.
Breast Cancer Research and Treatment|November 28, 2017
Evaluation of applying IHC4 as a prognostic model in the translational study of Intergroup Exemestane Study (IES): PathIESM C U Cheang, J M Bliss, G Viale, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2011
Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IXS Aebi, Z Sun, D Braun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2011
Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancerP Karlsson, Z Sun, D Braun, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 12, 2021
Management of breast cancer patients during the peak of the COVID 19 pandemicE Montagna, F Bellerba, C Sangalli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 4, 2008
Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancerG Gruber, B F Cole, M Castiglione-Gertsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2022
Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized studyL Gianni, C S Huang, D Egle, et al.
ESMO Open|August 10, 2023
Retrospective study to estimate the prevalence and describe the clinicopathological characteristics, treatments received, and outcomes of HER2-low breast cancerG Viale, M Basik, N Niikura, et al.
European Journal of Cancer (Oxford, England : 1990)|February 3, 2024
Multiplexed high-throughput immune cell imaging in patients with high-risk triple negative early breast cancer: Analysis from the International Breast Cancer Study Group (IBCSG) Trial 22-00S Rusakiewicz, S Tyekucheva, S Tissot-Renaud, et al.
Pageof 31